United States Pharmaceuticals and Healthcare Report Q1 2008

Published by: Business Monitor International

Published: Feb. 2, 2008 - 113 Pages

Table of Contents

Executive Summary

US Pharmaceuticals And Healthcare Industry SWOT

Pharmaceutical Business Environment Rating

Pharmaceutical Ratings - Revised Methodology

Ratings Overview

Table: Pharmaceutical Business Environment Indicators

Weighting

Table: Weighting Of Components

United States Business Enviroment Ranking

Table: Americas Pharmaceutical Business Environment Rankings

Limits To Potential Returns

United States - Market Summary

Regulatory Regime

Intellectual Property Developments

Pricing And Reimbursement Issues

Industry Developments

Healthcare sector

Universal Healthcare

Table: US Health Insurance Key States, 2005

Part D

Democrats Controlling Congress

Biotechnology Sector

Table: Biotechnology Medicines Under Development, 2006

Table: Top 10 2006 Biotech IPOs

Statins

Advertising Sector

Product Approvals

Mergers And Acquisitions

Marketing Sector

Reseach And Development Sector

Generics Sector

Wal-Mart Enters The Fray

Authorised Generics

Biogenerics

Canadian Imports

Pharmacy Sector

Manufacturing Sector

Industry Forecast Scenario

Overall Market Forecast

Table: US Pharmaceuticals And Healthcare Sector - Historical Data And Forecasts

Key Growth Factors - Industry

Key Growth Factors - Macroeconomic

Table: United States - Macroeconomic Forecasts

Prescription Market Forecast

Table: US Pharmaceuticals And Healthcare Sector - Historical Data And Forecasts (US$mn unless othewise stated)

OTC Market Forecast

Table: OTC Market Indicators (US$mn unless otherwise stated)

Generics Market Forecast

Table: Generics And Patented Market Indicators

Export/Import Forecasts

Table: US Pharmaceuticals And Healthcare Sector (US$mn)

Other Healthcare Data

Table: US Pharmaceuticals And Healthcare Sector

Table: US Pharmaceuticals And Healthcare Sector

Competitive Landscape

Overview

Market Data

Table: Leading 10 Therapeutic Classes by US Sales, 2006

Table: Leading 10 Products By US Sales, 2006

Table: Leading 10 Corporations By US Sales, 2005

Table: Leading 10 Corporations By Total US Dispensed Prescriptions, 2006

Table: Chanel Distribution By US Dispensed Prescription Chanel, 2006

Table: Channel Distribution By US Sales, 2006

Table: Leading 10 Products By Total US Dispensed Prescriptions, 2006

Table: HMG-COA Reductase Inhibitors (statins) - Total US Sales (US$’000)

Table: Proton Pump Inhibitors - Total US Sales (US$’000)

Table: Antidepressants (includes SSRI, SNRI and newer generation) - Total US Sales (US$’000)

Table: Antiarthitics, COX-2 Inhibitors - Total US Sales (US$’000)

Table: Sexual Function Disorder - Total US Sales (US$’000)

Company Profiles

Pfizer

GlaxoSmithKline (GSK)

Novartis

Merck & Co

Eli Lilly

Bristol-Myers Squibb (BMS)

Amgen

Genentech

BMI Forecast Modelling

How We Generate Our Industry Forecasts

Pharmaceutical Industry

Sources

Abstract

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.